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Abstract
Background: Cervicogenic headache is a prevalent and costly pain condition commonly treated by chiropractors.
There is evidence to support the effectiveness for spinal manipulation, but the dose of treatment required to
achieve maximal relief remains unknown. The purpose of this paper is to describe the methodology for a
randomized controlled trial evaluating the dose–response of spinal manipulation for chronic cervicogenic
headache in an adult population.
Methods/Design: This is a mixed-methods, two-site, prospective, parallel groups, observer-blind, randomized
controlled trial conducted at university-affiliated research clinics in the Portland, OR and Minneapolis, MN areas.
The primary outcome is patient reported headache frequency. Other outcomes include self-reported headache
intensity, disability, quality of life, improvement, neck pain intensity and frequency, satisfaction, medication use,
outside care, cervical motion, pain pressure thresholds, health care utilization, health care costs, and lost productivity.
Qualitative interviews are also conducted to evaluate patients’ expectations of treatment.
Discussion: With growing concerns regarding the costs and side effects of commonly used conventional treatments,
greater numbers of headache sufferers are seeking other approaches to care. This is the first full-scale randomized
controlled trial assessing the dose–response of spinal manipulation therapy on outcomes for cervicogenic headache.
The results of this study will provide important evidence for the management of cervicogenic headache in adults.
Trial registration: ClinicalTrials.gov (Identifier: NCT01530321)
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Background
Headaches are a common, disabling condition with a
substantial public health and financial impact on society
[1]. Approximately half to three quarters of the global
population experiences a headache during their life [2],
and the financial costs on society are huge. It is esti-
mated that 157 million days of work are lost each year
due to headaches, costing approximately $50 billion in
work absenteeism and medical benefits [3]. Neck pain is
common among headache sufferers [4], and secondary
headache pain referred from a neck disorder is defined
as cervicogenic headache (CGH) [5]. The point preva-
lence for CGH ranges from 0.4 to 4.6% [6–8] and up to
18% of the chronic headache population due to variation
in its definition [9].
Because of the growing concerns about harmful side
effects from over utilized pain medication [10], there is a
great need to investigate effective, safe, and cost-effective
complementary and integrative health therapies for
headache conditions. About 34% of US adults use such
therapies annually [11], many for headache and neck
pain [12, 13]. Spinal manipulative therapy (SMT), a
commonly used treatment for headache [4], is among
the most common [14].
A growing body of literature supports the use of SMT
for headache and no other intervention has been shown
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to be superior for the care of CGH [15–18]. Efficacy of
SMT for the relief of chronic CGH has been summa-
rized in systematic reviews [15, 19]; one review however
found insufficient evidence to reach a conclusion [20].
Most randomized controlled trials found evidence of
efficacy for SMT for CGH frequency, intensity and
duration [4, 21–23], specifically compared to deep
massage [24] and no treatment [25]. Despite this, there
remains little consensus on what constitutes an appropri-
ate dose of manipulation needed to achieve maximal
benefit [26–30]. Preliminary studies suggest a dose–
response relationship for SMT in the management of
CGH [27, 29]. One pilot RCT (n = 24) examined dif-
ferences between three doses: 3, 9, or 12 SMT visits
and found preliminary benefits with larger doses [27].
A second (n = 80) compared 8 and 16 SMT visits and
found clinically important differences between SMT
and the control and small differences between the two
doses for a number of headache outcomes [29]. This
is the first full-scale randomized controlled trial to in-
vestigate this relationship.
Study aims
The primary aim is to determine the effect of SMT visits
on self-reported clinical outcomes and objective physical
measures in 256 adults with chronic CGH (≥3 months),
measured at 12 and 24 weeks. The primary outcome is
patient-rated CGH frequency measured in days in the 4
weeks prior to these time points. Our hypothesis is that
a greater number of SMT treatments leads to a greater
reduction in CGH frequency. The secondary aim is to
determine the cost-effectiveness and cost-utility of the
number of SMT treatments for the care of chronic
CGH. The tertiary aim is to assess the effects of expecta-
tions on outcomes using mixed-methods in order to




This study is a two-site, prospective, parallel groups,
observer-blinded, randomized controlled trial. The trial
began in August 2012. Participants are recruited at North-
western Health Sciences University in Bloomington, MN
and the University of Western States in Portland, OR.
Study treatments are provided within university-affiliated
outpatient clinics. The study design is based on a previous
pilot randomized controlled trial [29].
Funding and ethical approval
The trial is funded by the National Institutes of Health
National Center for Complementary and Integrative
Health (R01AT006330). Ethical approval is granted by
the Institutional Review Boards (IRB) at the two
participating institutions (IRB20110127 and ID 1-98-
10-11). The trial is registered on ClinicalTrials.gov
(Identifier: NCT01530321), and informed consent is
obtained from all participants.
Recruitment
Potential subjects are recruited from Minneapolis, MN,
Portland, OR and their surrounding metropolitan com-
munities using multiple recruitment methods. These in-
clude systematic mailings of study post-card mailers,
online advertisements (Craigslist, Facebook, news web-
sites), local radio, newspaper and community postings,
and referrals from community medical clinics.
Study population
Adults, age 18 and older with a history of chronic
CGH are eligible to participate. The eligibility criteria
are described in Table 1. Participant flow (Fig. 1) data
are recorded in accordance with the Consolidated
Standards of Reporting Trials (CONSORT) [31] state-
ment and will be reported with final study results.
Changes to the study protocol
Initially, participants with a history of migraine head-
aches in the last year were excluded. In the second year
of the study, this criterion was modified to exclude par-
ticipants who had >1 migraine headache day per month
in the last year. The primary rationale for this change
was to enhance recruitment and enrollment at both
sites. The likelihood that this change is a major con-
founder is low due to the infrequent nature of included
migraine headaches, the distinct nature of the symptoms
[5], and study participants ability to recognize migraine
and cervicogenic headaches as different. In addition, the
analysis was modified to include stratification by the
presence or absence of migraine headaches.
Definition and diagnosis of cervicogenic headache
CGH is identified as a distinct classification of head-
ache by the International Classification of Headache
Disorders [5]. The diagnostic criteria used are shown
in Table 2 [32]. Criterion D is not used to diagnose
cervicogenic headache or determine enrollment in this
study; this criterion is not relevant in prospective
treatment studies.
Participants undergo a thorough headache history at
baseline to confirm a temporal sequence exists linking
the headache to the neck. A manual exam of the cer-
vical spine is conducted to identify areas of joint dys-
function [33]. Participants who meet these criteria,
without symptoms suggestive of a different headache
(e.g., prodromal aura, sensitivity to light and sound),
are diagnosed with CGH.
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Eligibility determination
Phone screen
Potential participants respond to recruitment materials
and trained interviewers conduct telephone screens to
assess obvious eligibility criteria. Suitable candidates are
then scheduled for the first of two baseline evaluation
appointments within 60 days of the phone screen.
Baseline 1 evaluation
The first baseline evaluation (BL1) includes an in-person
informed consent. Participants complete a self-report
questionnaire, and undergo a health history, physical
examination, and cervical radiographs, which are used to
rule out contraindications to treatment (e.g., diffuse idio-
pathic skeletal hyperostosis, severe degenerative joint
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
- 18 years of age and older
- History of CGH ≥ 3 months at Baseline 1,
≥5 days of CGH per month
- CGH intensity ≥3 (0–10 scale)
- Cervical spine dysfunction
(cervical joint tenderness and/or
restricted segmental motion)
- Clear temporal sequence linking
the source of CGH to the neck:
headache preceded by neck pain, stiffness,
movement and/or awkward postures
- English literate
- Independent ambulation
- Other headaches within one year of enrollment (e.g. migraine occurring on >1 day per
month in the last year, medication overuse, daily, cluster, temporomandibular joint
dysfunction related headaches, sinus, posttraumatic, tumor and glaucoma related, occipital
neuralgia, metabolic/toxic/substance abuse related).
- Spinal manipulative therapy, massage or exercise therapy for neck pain or headaches in the
previous 3 months. Any other types of care by a licensed provider in the previous month for
headaches or neck pain
- Contraindications to study treatments (e.g., inflammatory arthropathies, cervical instability,
severe osteoporosis, vertigo, dizziness)
- Daily prescription or nonprescription pain medication; corticosteroid use in previous month
- Cancer in the past five years
- Cardiovascular comorbidities (e.g., history of stroke, transient ischemic attacks, stage 2
hypertension, taking anticoagulant medication, syncope, myocardial infarction, hemophilia)
- Neurological comorbidities (e.g., multiple sclerosis, ALS, Parkinson’s, myelopathy, seizures,
cervical radiculopathy, herniated disc, thoracic outlet syndrome, brachial plexus neuropathy)
- Spinal pathology (e.g., infection, tumor, fracture, diffuse idiopathic skeletal hyperostosis,
degenerative joint disease, stenosis)
- Involved in a research study about pain
- Active or pending medical litigation, personal injury, workers compensation; disability
compensation
- Noncompliance with headache diary at baseline (<24/28 days completed);
pre-randomization noncompliance
- Pregnancy, trying to get pregnant, 3 months post-partum
- Brain or cervical spine surgery in previous 5 years; trauma to head or neck requiring
hospitalization in previous year
- Severe, unmanaged depression
Fig. 1 Participant flow
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disease). Previous medical records are also obtained as
needed to rule out contraindications. A trained and cer-
tified examiner performs a blinded, objective assessment
of cervical spine motion, and static and dynamic pain
pressure thresholds. Qualified participants at BL1 are
scheduled 4 weeks later for the baseline 2 screening
evaluation (BL2). In the interim, participants complete a
daily headache diary to capture CGH frequency and in-
tensity, medication use, and other types of headaches.
Case review meetings
Following BL1, study personnel review each case weekly
to determine preliminary study eligibility. Patient safety
and compliance concerns are also addressed. These
meetings ensure consistent interpretation and applica-
tion of the pre-defined eligibility criteria. Consensus is
reached for all cases and recommendations for inclu-
sion, exclusion, or follow-up care are made.
Baseline 2 evaluation and first treatment
Participants recommended for inclusion at case review
return for the BL2 screening evaluation. This includes
review of informed consent and completion of a self-
report questionnaire. Headache diaries completed during
the 4-week baseline period are collected, and eligibility
is confirmed using checklists. Eligible patients are ran-
domly assigned to one of 4 treatment groups by blinded
study staff, receive their first of 18 treatments, and begin
the second headache diary.
Treatment allocation and concealment
An adaptive computer-generated rank-minimization
scheme is used to allocate eligible participants to treat-
ment [34]. The computer program balances 7 blocking
variables separately for each of the 2 sites and is strati-
fied by the presence of infrequent migraine headache:
age, gender, CGH frequency and intensity, previous
experience and confidence in SMT and professional
massage therapy, and concomitant tension-type head-
ache. Allocation concealment is protected by the use
of balancing variables for rank minimization collected
immediately prior to enrollment. Also, the number of
participants previously randomized to each group is
concealed from the study personnel involved in eligi-
bility determination.
A computer generated random allocation sequence se-
cured in sequentially numbered, opaque envelopes ran-
domized within blocks is used to randomize the first
several participants at each site to provide a “seed” group
of participants for the dynamic allocation program. Enve-
lopes are also used in the rare case of rank minimization
program malfunction. Envelopes are created by the study
statistician such that treatment allocation and block sizes
are concealed from all study personnel.
Interventions
Treatments are provided at university-affiliated clinics
by licensed chiropractors with 6–35 years of clinical
experience. At the Minnesota site, treatments are pro-
vided in a university research clinic. Treatments at the
Oregon site are provided at one university clinic and 9
private chiropractic clinics. Participants commit to three,
10-min visits per week for 6 weeks (18 visits total), and
the 10-min visits are standardized across sites. In the
first 5 min, a moist hot pack is applied to relax neck and
upper back musculature; cold packs are used for acute
exacerbations. During this time, the chiropractor con-
ducts a brief history, including subjective headache and/
or neck complaints, patient progress, complications and
medication changes. In the remaining 5 min, a standard-
ized exam of the cervical and upper thoracic spine and
musculature (occiput to 3rd thoracic vertebra) is per-
formed to identify sites of joint dysfunction to be
treated. This includes manual palpation for segmental
motion restriction, tenderness, and osseous asymmetry,
as well as decreased global range of motion [35]. The
study treatment is then delivered (Table 3). No other
care is provided.
To minimize intervention bias and confounding by
contextual effects introduced by the provider during
care, chiropractors are trained to interact with patients
with equal enthusiasm for treatments across groups.
Data regarding patients’ perceptions of their provider’s
enthusiasm and confidence in the assigned study care
are collected on questionnaires during and immediately
following treatment (week 6) [26].
Table 2 Cervicogenic headache diagnostic criteria (ICHD 2nd Edition)
A. Pain, referred from a source in the neck and perceived in one or more regions of the head and/or face, fulfilling criteria C and D.
B. Clinical, laboratory and/or imaging evidence of a disorder or lesion within the cervical spine or soft tissues of the neck known to be,
or generally accepted as, a valid cause of headache.
C. Evidence that the pain can be attributed to the neck disorder or lesion based on at least one of the following:
1. Demonstration of clinical signs that implicate a source of pain in the neck.
2. Abolition of headache following diagnostic blockade of a cervical structure or its nerve supply using placebo- or other adequate control.
D. Pain resolves within 3 months after successful treatment of the causative disorder or lesion.
Key: ICHD international classification of headache disorders
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Standardized forms are used to document treatment
procedures and side effects, and all forms are reviewed
for protocol deviations and adverse events. Participants
are asked to refrain from seeking care for their CGH
and neck pain from other providers during the baseline
and treatment periods; however, abortive analgesics are
permitted as needed. Outside care is unrestricted follow-
ing the treatment phase; data regarding non-study care
is collected on self-report questionnaires.
Treatment providers are trained and certified to ensure
standardization in intervention and documentation across
study sites. Quality assurance includes meetings with pro-
viders to review treatment protocols and discuss uniform
enthusiasm for both interventions. Meetings occur quar-
terly in Year 1 and biannually thereafter to ensure
uniformity of care. Quality control measures are imple-
mented to ensure compliance with the study protocol.
Specifically, treatment forms are reviewed for completion
after each visit, and all clinicians are observed at predeter-
mined intervals throughout the active treatment phase.
Following investigator, or designee observations, providers
are recertified monthly in Year 1 and quarterly thereafter.
Further, participants’ perception of their clinicians’ enthu-
siasm for care is used to give feedback to clinicians if im-
balances across treatment groups are found.
Spinal manipulation
Spinal manipulation therapy (SMT) consists of the di-
versified thrust maneuver as described by Peterson and
Bergmann [35]. The need for SMT is assessed at each
visit via patient progress and a manual cervical palpa-
tion exam [35]. The clinician documents the sites of
dysfunction and manipulates some or all dysfunctional
regions based on the patient’s tolerance. SMT is not
performed if there are no signs of joint dysfunction
(i.e., palpable joint pain and/or restriction) or if a new
contraindication exists. Modifications to high velocity,
low amplitude manipulations are made for older partic-
ipants and those with acute exacerbations (i.e., low-
velocity, low-amplitude mobilization) [35]. Other chiro-
practic techniques are not permitted.
Light massage
Light massage consists of gentle effleurage and pétris-
sage applied to the neck and shoulder muscles [35, 36].
Clinicians use massage lotion, focus on the site of pain
and dysfunction, and gently squeeze tender points to
reinforce the sensation of therapy. Manual trigger point
therapy is not permitted. Dose–response trials require a
manual comparison group to control for attention and
therapeutic touch, in this case visits without spinal ma-
nipulation therapy. In a trial comparing SMT and light
massage, a minimal light massage was credible to par-
ticipants [29].
Treatment dose
Participants are randomized to one of four doses (n = 64
per group): 0, 6, 12, or 18 SMT visits. All participants
are assigned 18 total visits. When participants do not re-
ceive the index therapy (SMT), they receive the control
therapy (light massage).
Data collection
Patient self-reported outcomes are collected at baseline
and 6, 12, 24, 39, and 52 weeks post randomization
using headache diaries and questionnaires. Objective
spinal biomechanical outcomes and pain pressure
thresholds are collected at BL1 and at 6 weeks (end of
treatment). Qualitative interviews are also conducted at
the end of treatment. Study data is managed using Re-
search Electronic Data Capture (REDCap) tools hosted
at the University of Western States [37].
Headache diary
The International Headache Society (IHS) recommends
using a daily headache diary to capture headache out-
comes in efficacy trials [38]. An electronic diary, the pre-
ferred method, is sent to participants using a Short
Message Service (SMS) or email response (SMS-Track
ApS, Denmark https://www.sms-track.com/). Paper diar-
ies are provided to participants without daily Internet or
mobile phone access and are used as a back-up when
the electronic platform is not available. Enrolled
Table 3 Treatment interventions
Intervention Spinal manipulation therapy Light massage therapy
Type High Velocity, low amplitude
Low Velocity, low amplitude
(older patients or acute exacerbations only)
Gentle effleurage (gliding)
Gentle petrissage (kneading)
Location Cervical spine (Occiput -C7) Thoracic spine (T1-T3) Cervical spine musculature (Occiput -C7)
Thoracic spine musculature (T1-T3)
Design & delivery format Individualized: spinal levels treated, technique position
(e.g., seated, supine, prone)
Individualized: site of pain/dysfunction
Prone position
Delivery method One-on-one treatment visit One-on-one treatment visit
Dose 10 min 3 visits per week for 6 weeks 10 min 3 visits per week for 6 weeks
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participants complete 6 headache diaries: one at baseline
(to determine study eligibility), one during the treatment
phase, and four during the follow-up phase. Diary ques-
tions are found in Table 4.
Email or SMS options are available to participants
depending on patient preferences. Automatic SMS
messages (i.e., text-messages) or emails are sent to par-
ticipants each night during the data collection period,
and participants are given 24 h to respond. Participants
who fail to respond during the designated time period
cannot retroactively complete the diary. For those
whose preference is email, 1 email is sent to the partic-
ipant’s preferred address containing four questions
(Table 4). Participants respond to the questions, submit
their responses, and receive a thank you notification
confirming successful delivery and data capture. Partic-
ipants who chose the SMS option receive four individ-
ual SMS messages, one for each of the four questions.
Paper diaries are mailed in advance.
Outcomes
Primary aim: dose–response
CGH frequency The primary outcome measure is self-
reported CGH frequency, measured as the number of
days with CGH in the 4 weeks prior to weeks 12 and 24
using a headache diary. The IHS guidelines for con-
trolled trials recommend headache frequency as the
most appropriate primary measure in efficacy trials [38].
Participants are also asked to recall the number of CGH
days in the past 4 weeks on questionnaires, which are
used as backup to the diaries. These time points were
chosen to include short and long-term primary out-
comes. CGH frequency measures at 6, 39, and 52 weeks
are secondary outcomes (Table 5).
CGH pain Patient-rated headache intensity is the prin-
cipal secondary outcome and is measured using the
valid and reliable 11-point numerical rating scale [39].
Intensity is the average of daily pain rated over four
weeks on the headache diary. Diaries are backed-up by
participants recall of their average pain over the last 4
weeks collected on the questionnaires using the same
scale. Evaluation of headache pain is recommended by
the IHS [38].
Disability Patients rate their headache-related disability
using the valid and reliable Headache Impact Test (HIT-6)
[40]. This 6-item survey is administered at BL2 and fol-
lowing the intervention phase.
Quality of life This is collected using the EuroQol-5D, a
multi-attribute utility scale. The 5 dimensions (mobility,
self-care, usual activities, pain/discomfort, and anxiety/
depression) are evaluated with three levels (no, moderate
or severe problem). This will be used to compute
quality-adjusted life years for the cost-utility analysis.
This is a commonly employed instrument with sound
psychometric properties [41, 42].
Improvement Patient-rated global improvement is de-
termined by asking participants to compare their head-
ache condition to what it was before study treatment
on a 9-point ordinal scale ranging from no symptoms
(100% improvement) to as bad as it could be (100%
worse). Improvement has been shown to be reliable
and responsive [43]. Improvement in CGH pain is also
evaluated on a −10 to +10 numerical rating scale.
Other headache days Participants indicate whether
they have headaches other than cervicogenic on the
headache diary. The sum of headache days in the last 4
weeks is used.
Neck pain frequency Self-reported neck pain frequency,
measured in days, is collected on the mailed question-
naires. Participants are asked if they had neck pain over
the last four weeks (yes or no), and if so, how many days
they had neck pain (1–28 days).
Neck pain Participants are asked to rate their average
neck pain over the past 4 weeks using the valid and reli-
able 11-box numerical rating scale (0 = no pain, 10 worse
pain possible) [39]. Participants with spinal problems con-
sider pain to be an important outcome measure [44].
Satisfaction Participants overall satisfaction with treat-
ment is measured using a 6-point Likert scale ranging
from extremely dissatisfied to extremely satisfied. This
scale is adapted from the Interstudy’s Low Back Pain
TyPE Spec [45].
Table 4 Diary questions
Diary questions Response options
1. Did you take medication for a neck-related headache today? 1. Yes or No
2. Did you have a neck-related headache today? 2. Yes or No
3. If yes, rate your neck-related headache today? 3. 11-box numerical rating scale (0 = no pain, 10 = worst pain possible)
4. Did you have a headache not related to your neck? 4. Yes or No
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Medication use Participants report frequency of over-
the-counter and prescription medication use on diaries
and questionnaires. The daily diary asks: “Did you take any
medication for a neck-related headache today?” (yes or no).
Outside care Discretionary professional care outside the
study, including emergency care and hospitalizations
rendered for CGH, is captured on questionnaires. Partic-
ipants are asked, “In the past four weeks, have you seen
any healthcare provider for your neck related head-
aches?” (yes or no). If yes, participants indicate which
type of provider they visited and the frequency of visits.
Cervical kinematics These are evaluated using the
Zebris CMS-HS Spine Motion Analyzer (Zebris Inc.,
Isny im Allgau, Germany) and a modified protocol de-
scribed by Wang [46]. This reliable and accurate tool
has been used in other RCTs [46–49]. Flexion, exten-
sion, lateral flexion and rotation, coupled out of plane
motion, and maximum accelerations and velocities in
these planes are recorded.
Pressure pain threshold These are evaluated using a
hand-held algometer (Wagner Instruments. Force One™
Digital Force Gage. FDIX. Greenwich, CT, USA) applied
to standardized locations along the cervical and upper
thoracic spine. In addition, pain pressure thresholds are
assessed at areas identified as clinically important by the
examiner using manual palpation techniques [35]. Exam-
iners are trained across sites to apply pressure at a rate
of approximately 1kg/s until pain is elicited. This is a re-
liable method for ascertaining pain pressure thresholds
[50] and is shown to be associated with outcomes [30].
Secondary aim: cost-effectiveness
Direct and indirect healthcare costs are included. Direct
costs are determined from health services utilized and
indirect costs from lost productivity [51].
Healthcare utilization The utilization of health services
for headache not provided in the study are captured on
questionnaires at all-time points. Health services include
physician and other provider visits, hospital services,
prescription and non-prescription medication, advanced
Table 5 Data collection schedule
Outcomes Variables BL1 BL2 2W 6W 12W 24W 39W 52W
Background Demographics; comorbidities Q
Duration of episode; history of SMT and massage care Q
Primary Objective Dose-Response
Headache CGH frequency in 4 weeks prior Q D, Q D, Q D, Q D, Q D, Q D, Q
CGH pain Q D, Q D, Q D, Q D, Q D, Q D, Q
CGH disability Q Q Q Q Q Q
CGH improvement: pain, global perceived effect Q Q Q Q Q
Other headache days D, Q D, Q D, Q D, Q D, Q D, Q
Neck Pain Frequency (days) of neck pain Q Q Q Q Q Q Q
Quality of Life EuroQol-5D Q Q Q Q Q
Satisfaction Likert Scale, success of care Q Q Q Q Q
Medication Frequency of prescription and non-prescription medication (days) D, Q D, Q D, Q D, Q D, Q D, Q
Outside Care CGH care from external providers Q Q Q Q Q Q Q
Objective Measures Kinematics and cervical segmental joint function X X
Secondary Objective Cost Effectiveness
Healthcare Utilization
and lost productivity
Q Q Q Q Q Q
Utilities Quality-adjusted life years EuroQol-5D Q Q Q Q Q
Outcomes CGH frequency (days) and intensity (in last 4 wks) Q D, Q D D D D D
Tertiary Objective Effects of Expectations
Quantitative Confidence in treatment success Q Q Q Q Q Q Q
Perceptions of the Patient-provider encounter Q Q
Qualitative Meaning, constructs of expectations I
Key: BL baseline, SMT spinal manipulation therapy, W weeks, CGH cervicogenic headache, Q questionnaire, D diary, I interview, X indicates occurrence
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imaging, and classes/programs attended. Questions from
the Community Tracking Study Household Survey [52]
are used to capture provider and hospital services. Infor-
mation for other service is ascertained using an instru-
ment developed for a low back pain study [53]; this was
also used in a CGH pilot study [29].
Lost productivity Indirect costs, which include lost
workdays and productivity, are assessed using three ques-
tions from the National Health Interview Survey [54].
Lost productivity data is captured on questionnaires.
Tertiary AIM: effects of expectations
Qualitative interviews One-on-one (face to face), semi-
structured qualitative interviews are conducted by trained
research staff at week 6. An interview schedule is used to
direct the interviews and keep interviewers on track with
the study’s objective. Participants are asked about their
treatment views, expectations and lived experience with
headaches. Questions start broadly and are followed-up
with probing questions to elicit additional information.
Confidence in treatment success This is measured
using a 7-point Likert scale adapted from the Interstudy’s
Low Back Pain TyPE Spec [45]. Potential success is
assessed at baseline and week 2. Confidence that assigned
treatment is working is measured at all follow-up time
points.
Perceptions of the patient-provider encounter Per-
ceptions are evaluated at weeks 2 and 6 and are used to
determine the effect of the patient-provider experience
on expectations and outcomes [26, 29]. The instrument
used is based on the satisfaction questionnaire by Cherkin
et al. [55, 56]. Specifically, participants are asked about
their level of agreement with statements about their per-
ception of the treating chiropractors’ adequate time spent
listening, comfort with dealing with CGH, enthusiasm
about the treatment program, and confidence that treat-
ment will work.
Blinding
Research staff who perform clinical and objective exami-
nations and data entry are blinded to treatment assign-
ment. Providers and participants are initially blinded to
dose and the treatment hypotheses; however, treatment
dose becomes apparent over time. Due to the nature of
the SMT and light massage treatments, providers and
patients are not blinded to treatments at each visit.
Qualitative interviewers and project managers at both
sites are not blinded.
Adverse events
Incomplete reporting of adverse events remains a prob-
lem in clinical trials investigating therapies for CGH
[57]. To address this, we use standardized and system-
atic recording and reporting of unanticipated and antici-
pated events. Enrolled participants are queried at each
treatment visit and following the treatment phase (week
6) about problems, complications to care, or adverse
events since their last appointment. During the follow-
up data collection phase, participants are asked whether
they spent >24 h in bed and/or if they were hospitalized
for any reason on questionnaires; research staff contact
participants by phone if an event occurred. Documenta-
tion of such events occurs on a standardized case report
form which includes a severity rating, relatedness of the
event to study participation, and whether the event was
anticipated. Further, participants are asked to report ser-
ious adverse events to the study investigators or research
staff. Oversight authorities (i.e., IRBs, funding agency)
are informed about serious, reportable adverse events
within three business days of the event first being identi-
fied. Non-reportable events are summarized for the data
safety and monitoring board annually.
Analysis plan
Primary aim: dose–response
Primary analysis Both primary and secondary variables
will be regressed on dose, baseline value of the outcome,
site indicator (Portland or Minneapolis), and 6 baseline
balancing variables used for randomization in the rank-
order minimization computer program (CGH days, CGH
pain, gender, age, tension-type headache indicator, and dif-
ferential confidence in success of SMT and LM) [58]. The
analysis will be stratified by migraine headache. Dose will
be included in two separate ways: as a linear/nonlinear
function and as a set of indicator variables to make com-
parisons between the SMT groups and the control group.
Seemingly unrelated (simultaneous) regression by Zellner
[59] will be used in the analysis for the individual time
points [60]. For the primary outcomes only, longitudinal
effects across all follow-ups will be modeled with genera-
lized estimating equations to account for within-person
correlation between time points [60]. An intention-to-
treat analysis will be conducted with participants included
in the original allocation group. Missing data will be
imputed by interpolating between adjacent times, or by
carrying forward when there is no subsequent data. An
intention-to-treat analysis will be conducted with partici-
pants included in the original allocation group. Missing
data will be imputed by interpolating between adjacent
times, or by carrying forward when there is no subsequent
data. This method was used in our pilot study [28] and
full-scale, dose–response randomized trial on manipula-
tion for low back pain [61] where the quantity of missing
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data was reasonably small. Sensitivity analyses 1) using
multiple imputation and 2) excluding imputed data will be
performed to assess the impact of missing data [62, 63].
Responder analysis CGH days, pain, and disability, as
well as neck pain will be dichotomized using a 50%
improvement threshold to define a responder. This is
a common measure of important improvement in
headache research [38]. The dichotomized data will
be analyzed using binomial regression models [60]
with the same independent variables as the primary
analysis to compare responder rates between groups.
Secondary aim: economic analysis
Incremental cost-effectiveness ratios (ICERs) will be
computed using adjusted between-groups differences in
costs (numerator) and effects (denominator). Incremental
cost-utility ratios will be computed replacing the denom-
inator with quality-adjusted life years (QALYs) derived
from the EuroQol EQ-5D [41, 42]. Regression analyses
will be used to model cost and effect separately to ad-
just each for potential confounding variables [64–66],
with bias-corrected and accelerated non-parametric
bootstrap used to address cost-data skewness [67].
Bootstrapped cost-effect pairs will be plotted on the
cost-effectiveness plane to assess the amount of uncer-
tainty surrounding ICER estimates. In addition, cost-ef-
fectiveness acceptability curves will be used to estimate
the probability of cost-effectiveness over a range of willing-
ness to pay thresholds [68].
The principal cost analysis will consider only the
scheduled treatment visits defined in this protocol. A
second approach will adopt a societal perspective includ-
ing all healthcare resources [51, 69, 70] and estimated
costs of lost productivity due to CGH [71, 72].
Tertiary aim: effects of expectation
Quantitative analysis The potential effects of patient
expectancy will be explored in a path analysis using
structural equation modeling [73, 74] as in our earlier
work [26, 75]. Dose effects will be included in a meas-
urement model, and expectancy variables will be per-
mitted to affect subsequent outcomes, as well as being
influenced by previous outcomes. Due to the limited
sample size, this analysis will be carried out as an ex-
ploratory analysis.
Qualitative analysis For the qualitative interviews, con-
tent analysis using an inductive approach [76] will be
used to identify categories and themes that occur in the
transcribed text [77]. Transcribed data will be entered
into a database designed to capture and analyze qualita-
tive data. The frequency of themes will be quantified
and representative quotations will be identified [77, 78].
The frequency of responses in the thematic categories
will be cross-tabulated with treatment group assignment
and compared for between group differences using Chi-
square analysis. 95% confidence intervals will be calcu-
lated for these differences.
Power analysis and sample size
A power analysis was conducted by simulating the pri-
mary analysis outlined above using the primary outcome,
CGH days. We will randomize 256 participants (n = 64/
group). Sample size is based on 80% power using a two-
sided test at the .05 level of significance. For the primary
outcome, CGH days, we will be able to detect a linear
dose effect (slope) of 1.1 CGH days (between two ad-
jacent doses) and a mean difference of 3.5 CGH days
between 2 groups. The residual standard deviation of
7 headaches (surrogate for days) was used, based on
regression analyses in the CGH pilot study [29]. The
study will also be appropriately powered for CGH in-
tensity, the principal secondary outcome.
Data and safety monitoring plan
University of Western States is the data coordinating
center responsible for the creation of case-report forms,
data transfer and management. The data and safety
monitoring board and 2 university institutional review
boards meet annually to review the study. Reportable ad-
verse events will be reviewed as they occur. No interim
analyses are planned due to the low risk profiles of the
interventions used in this study.
Study status
Enrollment is complete at the Minnesota and Oregon
sites. Follow-up data collection is ongoing thru 2016.
Discussion
This novel study is the first full-scale randomized
controlled trial aimed at identifying the dose of SMT
to treat cervicogenic headache in an adult population.
The long-term goal is to begin to set the clinical
study standards to establish criteria that can be used
to inform the decision-making process to 1) select opti-
mal chiropractic care protocols for future comparative
effectiveness trials and 2) determine the appropriate
number, frequency, and duration of various chiropractic
services for headache and other commonly treated
neuromusculoskeletal conditions. Further, the use of a
daily electronic headache diary to capture principal
headache outcomes in real-time in both the short and
long-term provides data arguably less subject to recall
bias compared to other platforms such as paper diaries.
To our knowledge, electronic diaries have not been used
to collect headache outcomes in other CGH studies.
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Headache is the most common pain condition resulting
in lost work productivity, but cost data specific to CGH
is lacking in the US [71]. Secondary outcomes used in
this study will provide important information about the
cost-effectiveness of SMT for CGH in adults. Further,
several studies suggest a link between patient expecta-
tions and health outcomes [79–81]. However, in a pilot
RCT, patient perception of the patient-provider inter-
action and patient expectations were balanced across
groups and demonstrated little effect on outcomes [26].
To our knowledge, this is the first trial to use a qualita-
tive and quantitative analysis to investigate the relation-
ship of SMT dose to possible correlates including patient
expectations, the patient-provider encounter, and head-
ache outcomes. Information gathered will help to inform
the design of future research and treatment regimens for
patients with costly and prevalent headache conditions.
Notably, the fastidious nature of this trial and its
methodologically rigorous design enhances internal val-
idity. Specifically, the treatments are compared under
tightly controlled conditions. Attention bias is controlled
by standardized 10-min visits, equal number of visits,
and restriction on concomitant care unassociated with
the study. Patient expectation is controlled, in the ab-
sence of blinding, by equal enthusiasm for care by each
chiropractor across treatment groups. The design also
isolates the effects of manipulation by controlling the
hands on time and attention from the chiropractor. In
addition, strict eligibility criteria minimize the heterogen-
eity of the study population. To determine eligibility and
ensure participant compliance, 2 baseline visits with a 4-
week headache diary in between is strictly adhered to.
Also, electronic diaries capturing headache outcomes are
closely monitored and patients are reminded regularly to
complete their diaries daily. To enhance generalizability,
multiple recruitment strategies are used and participants
are enrolled at 2 sites (West Coast and Midwest, USA).
Following completion of this trial, the study will provide
dosing information and methodologically sound clinical
evidence to inform the design of future comparative
effectiveness trials and establish treatment protocols
for patients suffering with CGH, a widespread and
costly condition.
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